---
title: "NAD+"
slug: "nad-plus"
type: "compound"
category: "Longevity"
url: "https://peptidesciencethailand.com/compounds/nad-plus"
description: "Intravenous NAD+ therapy aimed at restoring cellular coenzyme levels tied to energy, repair, and sirtuin activity. Research rationale and protocol overview."
---
# NAD+

*Essential Coenzyme, Direct Cellular Energy and DNA Repair Substrate Replenishment*

**Category:** Longevity  
**Format:** Auto-Injector Pen  
**Amount:** 1000mg  
**Purity:** >99.0% (HPLC)

## Overview

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, serving as a critical substrate for over 500 enzymatic reactions and functioning as the central electron carrier in cellular energy metabolism. NAD+ exists in two forms: the oxidized form (NAD+) and the reduced form (NADH), and the ratio between these two forms is a fundamental determinant of cellular metabolic state, redox balance, and signaling capacity. The molecule consists of two nucleotides joined through their phosphate groups, with one nucleotide containing an adenine nucleobase and the other containing a nicotinamide moiety, the active site of the molecule that participates in hydride transfer reactions.

The metabolic functions of NAD+ are vast and interconnected. In glycolysis and the citric acid cycle (Krebs cycle), NAD+ serves as an electron acceptor, being reduced to NADH as glucose and fatty acids are catabolized for energy production. NADH subsequently donates its electrons to Complex I of the mitochondrial electron transport chain, driving the proton gradient that powers ATP synthase to produce ATP, the universal energy currency of cells. Without adequate NAD+ availability, the flux through these central metabolic pathways becomes rate-limited, reducing cellular ATP production capacity and overall metabolic efficiency.

Beyond its role as a metabolic coenzyme, NAD+ serves as a consumed substrate for three major families of signaling enzymes that profoundly influence cellular health and longevity. Sirtuins (SIRT1-7) are NAD+-dependent protein deacetylases and deacylases that regulate gene expression, DNA repair, mitochondrial biogenesis, inflammation, and stress resistance. SIRT1, the most extensively studied sirtuin, deacetylates key transcription factors including PGC-1alpha (the master regulator of mitochondrial biogenesis), FOXO transcription factors (which control antioxidant gene expression), and NF-kB (the master inflammatory transcription factor). Each deacetylation reaction consumes one molecule of NAD+, meaning sirtuin activity is directly limited by NAD+ availability.

Poly(ADP-ribose) polymerases (PARPs), particularly PARP1, represent the largest consumer of cellular NAD+. PARPs detect and repair DNA damage by catalyzing the attachment of ADP-ribose chains to proteins at DNA damage sites, recruiting repair machinery. Each DNA damage repair event can consume 50-150 molecules of NAD+. Under conditions of chronic DNA damage, which increases with age and environmental stress, PARP activation can deplete NAD+ pools to levels that compromise sirtuin function and metabolic efficiency, creating a vicious cycle of declining cellular health.

CD38, a transmembrane glycoprotein enzyme, is the third major NAD+ consumer. CD38 hydrolyzes NAD+ to generate cyclic ADP-ribose (cADPR), a calcium-mobilizing second messenger involved in immune cell signaling and inflammation. Research has identified CD38 as the primary driver of age-related NAD+ decline, with CD38 expression and activity increasing substantially with age, particularly in immune and inflammatory cells. Studies in CD38 knockout mice demonstrate preserved NAD+ levels, maintained mitochondrial function, and resistance to metabolic decline with aging.

The age-related decline in NAD+ levels is one of the most consistently documented biochemical changes associated with aging. Studies in human subjects have demonstrated that NAD+ levels in tissues decline by approximately 50% between the ages of 40 and 60, with continued decline thereafter. This reduction has been mechanistically linked to multiple hallmarks of aging including mitochondrial dysfunction, genomic instability, epigenetic alterations, cellular senescence, and chronic low-grade inflammation ("inflammaging").

Direct NAD+ supplementation via subcutaneous injection bypasses the multi-step biosynthetic pathways required when using precursors such as NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside). While oral precursors must be absorbed, transported to target tissues, and enzymatically converted to NAD+ through rate-limited pathways, direct NAD+ administration delivers the coenzyme in its bioactive form. Research comparing delivery routes has demonstrated that parenteral NAD+ administration produces rapid and substantial increases in blood and tissue NAD+ levels, with measurable elevations within hours of administration.

The auto-injector pen format delivers 1000mg NAD+ in a pre-mixed solution, enabling precise subcutaneous administration without the lengthy intravenous infusion protocols (typically 2-4 hours) traditionally required for direct NAD+ delivery. This format represents a significant advancement in convenience and accessibility for NAD+ replenishment under specialist supervision.

## Mechanism of Action

### Step 1: Direct NAD+ Pool Replenishment

Subcutaneous NAD+ administration directly elevates intracellular NAD+ levels, bypassing the rate-limited biosynthetic conversion steps required by oral precursors (NMN, NR). Rapid increases in blood and tissue NAD+ concentrations are measurable within hours.

### Step 2: Sirtuin Activation (SIRT1-7)

Elevated NAD+ availability restores substrate supply for sirtuin deacetylases. SIRT1 activation deacetylates PGC-1alpha (mitochondrial biogenesis), FOXO factors (antioxidant defense), and NF-kB (inflammatory suppression), coordinately improving cellular resilience.

### Step 3: DNA Repair Capacity Restoration

Restored NAD+ pools provide adequate substrate for PARP1-mediated DNA damage repair without depleting the NAD+ available for sirtuin function. This resolves the NAD+ competition between DNA repair and metabolic regulation that characterizes aged cells.

### Step 4: Mitochondrial Electron Transport Optimization

NAD+/NADH redox cycling in glycolysis, the citric acid cycle, and Complex I of the electron transport chain operates at improved flux rates, restoring cellular ATP production capacity and metabolic efficiency toward younger baseline levels.

### Step 5: Inflammaging & Senescence Modulation

SIRT1-mediated NF-kB deacetylation suppresses chronic inflammatory gene expression. Improved NAD+ availability supports SIRT3 and SIRT6 functions in mitochondrial health and telomere maintenance, collectively addressing multiple molecular hallmarks of aging.

## Researched Benefits

### Cellular Energy Metabolism Support

NAD+ is the essential electron carrier for glycolysis, the citric acid cycle, and oxidative phosphorylation. Restoring NAD+ levels to youthful concentrations supports optimal ATP production across all cell types, which may manifest as improved physical energy, cognitive clarity, and exercise recovery capacity.

### Sirtuin-Mediated Longevity Pathway Activation

Sirtuins are NAD+-dependent enzymes that regulate mitochondrial biogenesis, antioxidant defense, DNA repair gene expression, and inflammatory suppression. Age-related NAD+ decline directly limits sirtuin activity. NAD+ replenishment restores sirtuin function, activating multiple longevity-associated molecular pathways simultaneously.

### DNA Repair Capacity Enhancement

PARP1-mediated DNA repair consumes substantial amounts of NAD+, and aged cells with depleted NAD+ pools have compromised repair capacity leading to genomic instability. NAD+ supplementation provides adequate substrate for DNA repair without depleting the pools needed for metabolic regulation and sirtuin function.

### Neuroprotective & Cognitive Support

Neural tissue has particularly high metabolic demands and NAD+ consumption. Research demonstrates that NAD+ depletion in the brain contributes to age-related cognitive decline and neurodegenerative processes. NAD+ replenishment supports neuronal mitochondrial function, synaptic energy supply, and sirtuin-mediated neuroprotective gene expression.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 100-250mg per administration, frequency determined by the your specialist based on individual assessment and NAD+ level testing |
| Route | Subcutaneous injection via auto-injector pen |
| Duration | Protocols vary from acute loading phases (daily for 5-7 days) to maintenance schedules (1-3 times weekly). Duration determined by specialist assessment. |
| Cycle Notes | Some protocols incorporate an initial loading phase with daily administration for 5-7 days, followed by maintenance dosing 1-3 times weekly. Periodic blood NAD+ level testing can guide dosing frequency. No established cycling requirement has been demonstrated in research. |
| Reconstitution | No reconstitution required. The auto-injector pen contains pre-mixed NAD+ solution at 1000mg total capacity. Store in refrigerator at 2-8 degrees C. Protect from light and heat. Use within the timeframe specified on the pen label after first use. |

> **Specialist note:** NAD+ supplementation requires assessment of baseline metabolic health, liver function, and consideration of current medications. Individuals with active malignancies should be evaluated carefully, as NAD+ metabolism is altered in cancer cells. Injection site reactions and flushing are common during initial administrations. A specialist will determine the appropriate dose and frequency.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Pre-filled Auto-Injector Pen |
| Amount | 1000mg per pen |
| Purity | >99.0% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Sequence | Nicotinamide Adenine Dinucleotide (C21H27N7O14P2) - not a peptide; a dinucleotide coenzyme |
| Molecular Weight | 663.43 g/mol |
| Storage | Store refrigerated at 2-8 degrees C. Protect from light. Do not freeze. Use within specified timeframe after first use. |
| Appearance | Clear, colorless to slightly yellow solution in pre-filled pen |

## Medical Guidance

NAD+ is a fundamental metabolic coenzyme with wide-ranging biological activity. While generally well-tolerated, its role in supporting cellular proliferation means individuals with active malignancies or history of certain cancers require careful specialist evaluation. NAD+ can interact with medications that affect mitochondrial function or liver metabolism. Baseline liver function, metabolic panel, and assessment of current medications are recommended before initiating supplementation. Flushing and warmth at injection sites are common initial effects that typically diminish with continued use.

## Frequently Asked Questions

### What is NAD+ and why does it decline with age?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell that is essential for energy production, DNA repair, and cellular signaling. It participates in over 500 enzymatic reactions. NAD+ levels decline approximately 50% between ages 40 and 60, primarily due to increasing activity of the CD38 enzyme, rising PARP-mediated DNA repair demand, and declining biosynthetic capacity. This decline is mechanistically linked to multiple hallmarks of aging.

### How does direct NAD+ differ from taking NMN or NR supplements?

Oral NAD+ precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) must be absorbed through the digestive tract, transported to target tissues, and converted to NAD+ through multi-step enzymatic pathways that are rate-limited. Direct subcutaneous NAD+ administration delivers the coenzyme in its bioactive form, bypassing these conversion steps and producing rapid, measurable increases in blood and tissue NAD+ levels.

### Does NAD+ supplementation require medical supervision?

Yes. While NAD+ is a naturally occurring molecule, supplementation at pharmacological doses requires specialist evaluation. Pre-treatment assessment should include metabolic panel, liver function tests, and screening for conditions where elevated NAD+ could be problematic. A specialist will determine appropriate dosing, frequency, and monitoring schedule based on individual health status and goals.

### What does NAD+ feel like when administered?

Subcutaneous NAD+ administration commonly produces temporary flushing, warmth, and tingling at the injection site and sometimes more broadly. These effects are typically mild, diminish within 15-30 minutes, and tend to lessen with continued use. Many recipients report increased alertness and energy in the hours following administration. These subjective effects are attributed to rapid improvements in cellular energy metabolism.

### What is the advantage of the pen format for NAD+ delivery?

Traditional direct NAD+ administration requires intravenous infusion over 2-4 hours in a clinical setting. The auto-injector pen enables subcutaneous delivery in minutes, making regular NAD+ replenishment practical outside of infusion clinic settings. The pen format provides pre-measured doses, eliminating manual preparation, and enables consistent administration under specialist-guided protocols.

## Related Compounds

- /compounds/epithalon
- /compounds/mots-c
- /compounds/ss-31